CCND1 and hepatocellular carcinoma: Previous research has shown that MCM7 promotes hepatocellular carcinoma (HCC) progression via the MCM7-cyclin D1 signaling pathway, suggesting its potential as a target for therapeutic intervention in hepatocellular carcinoma [18].